These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 34857160)

  • 21. Larger low voltage zone in endocardial unipolar map compared with that in epicardial bipolar map indicates difficulty in eliminating ventricular tachycardia by catheter ablation.
    Miyamoto K; Noda T; Satomi K; Wada M; Nakajima I; Ishibashi K; Okamura H; Noguchi T; Anzai T; Yasuda S; Ogawa H; Shimizu W; Aiba T; Kamakura S; Kusano K
    Heart Vessels; 2016 Aug; 31(8):1337-46. PubMed ID: 26266635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and relevance of nonreentrant monomorphic ventricular tachycardia in patients with frequent implantable cardioverter defibrillator interventions.
    Fiek M; Remp T; Fleckenstein M; Pohl T; Deiss M; Reithmann C
    J Interv Card Electrophysiol; 2015 Mar; 42(2):151-60. PubMed ID: 25620151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term benefit of first-line peri-implantable cardioverter-defibrillator implant ventricular tachycardia-substrate ablation in secondary prevention patients.
    Acosta J; Cabanelas N; Penela D; Fernández-Armenta J; Andreu D; Borràs R; Korshunov V; Cabrera M; Vasanelli F; Arbelo E; Guasch E; Martínez M; Tolosana JM; Mont L; Berruezo A
    Europace; 2017 Jun; 19(6):976-982. PubMed ID: 27353322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unmappable ventricular tachycardia after an old myocardial infarction. Long-term results of substrate modification in patients with an implantable cardioverter defibrillator.
    Alzand BS; Timmermans CC; Wellens HJ; Dennert R; Philippens SA; Portegijs PJ; Rodriguez LM
    J Interv Card Electrophysiol; 2011 Aug; 31(2):149-56. PubMed ID: 21340515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
    AbdelWahab A; Sapp J
    Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term success of a multi-electrode substrate mapping and ablation strategy versus a classic single tip mapping and ablation strategy for ventricular tachycardia ablation in patients with ischemic cardiomyopathy.
    Balt JC; Abeln BGS; Mahmoodi BK; van Dijk VF; Wijffels MCEF; Boersma LVA
    Pacing Clin Electrophysiol; 2023 Jul; 46(7):574-582. PubMed ID: 37254956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Recurrent ventricular tachycardias following myocardial infarction: linear ablation strategy using an electroanatomical mapping system].
    Horlitz M; Schley P; Shin DI; Ghouzi A; Klein RM; Gülker H
    Dtsch Med Wochenschr; 2005 Jul; 130(28-29):1683-8. PubMed ID: 16003602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substrate mapping vs. tachycardia mapping using CARTO in patients with coronary artery disease and ventricular tachycardia: impact on outcome of catheter ablation.
    Volkmer M; Ouyang F; Deger F; Ernst S; Goya M; Bänsch D; Berodt K; Kuck KH; Antz M
    Europace; 2006 Nov; 8(11):968-76. PubMed ID: 17043071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unipolar voltage threshold of 5.0 mV is optimal to localize critical isthmuses in post-infarction patients presenting with ventricular tachycardia.
    Enriquez A; Ali FS; Boles U; Michael K; Simpson C; Abdollah H; Baranchuk A; Redfearn D
    Int J Cardiol; 2015; 187():438-42. PubMed ID: 25841144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical ablation of refractory ventricular tachycardia in patients with nonischemic cardiomyopathy.
    Anter E; Hutchinson MD; Deo R; Haqqani HM; Callans DJ; Gerstenfeld EP; Garcia FC; Bala R; Lin D; Riley MP; Litt HI; Woo JY; Acker MA; Szeto WY; Zado ES; Marchlinski FE; Dixit S
    Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):494-500. PubMed ID: 21673018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial.
    Stevenson WG; Wilber DJ; Natale A; Jackman WM; Marchlinski FE; Talbert T; Gonzalez MD; Worley SJ; Daoud EG; Hwang C; Schuger C; Bump TE; Jazayeri M; Tomassoni GF; Kopelman HA; Soejima K; Nakagawa H;
    Circulation; 2008 Dec; 118(25):2773-82. PubMed ID: 19064682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sinus rhythm detection of conducting channels and ventricular tachycardia isthmus in arrhythmogenic right ventricular cardiomyopathy.
    Fernández-Armenta J; Andreu D; Penela D; Trucco E; Cipolletta L; Arbelo E; Berne P; María Tolosana J; Pedrote A; Brugada J; Mont L; Berruezo A
    Heart Rhythm; 2014 May; 11(5):747-54. PubMed ID: 24561159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonischemic cardiomyopathy substrate and ventricular tachycardia in the setting of coronary artery disease.
    Aldhoon B; Tzou WS; Riley MP; Lin D; Callans DJ; Hutchinson MD; Dixit S; Garcia FC; Zado ES; Marchlinski FE
    Heart Rhythm; 2013 Nov; 10(11):1622-7. PubMed ID: 23973949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relation of the unipolar low-voltage penumbra surrounding the endocardial low-voltage scar to ventricular tachycardia circuit sites and ablation outcomes in ischemic cardiomyopathy.
    Chopra N; Tokuda M; Ng J; Reichlin T; Nof E; John RM; Tedrow UB; Stevenson WG
    J Cardiovasc Electrophysiol; 2014 Jun; 25(6):602-8. PubMed ID: 24576211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of left ventricular scar and Purkinje-like potentials during mapping and ablation of ventricular fibrillation in dilated cardiomyopathy.
    Sinha AM; Schmidt M; Marschang H; Gutleben K; Ritscher G; Brachmann J; Marrouche NF
    Pacing Clin Electrophysiol; 2009 Mar; 32(3):286-90. PubMed ID: 19272055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patients treated with catheter ablation for ventricular tachycardia after an ICD shock have lower long-term rates of death and heart failure hospitalization than do patients treated with medical management only.
    Bunch TJ; Weiss JP; Crandall BG; Day JD; May HT; Bair TL; Osborn JS; Mallender C; Fischer A; Brunner KJ; Mahapatra S
    Heart Rhythm; 2014 Apr; 11(4):533-40. PubMed ID: 24333283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transseptal versus transaortic approach for radiofrequency ablation in patients with cardioverter-defibrillator and electrical storm.
    Pluta S; Lenarczyk R; Pruszkowska-Skrzep P; Kowalski O; Sokal A; Sredniawa B; Mazurek M; Kalarus Z
    J Interv Card Electrophysiol; 2010 Jun; 28(1):45-50. PubMed ID: 20180007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catheter Ablation of Scar-mediated Ventricular Tachycardia: Are Substrate-based Approaches Replacing Mapping?
    Hongo RH
    J Innov Card Rhythm Manag; 2019 Jun; 10(6):3707-3715. PubMed ID: 32477737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catheter Ablation of Ventricular Tachycardia as the First-Line Therapy in Patients With Coronary Artery Disease and Preserved Left Ventricular Systolic Function: Long-Term Results.
    Clemens M; Peichl P; Wichterle D; Pavlů L; Čihák R; Aldhoon B; Kautzner J
    J Cardiovasc Electrophysiol; 2015 Oct; 26(10):1105-10. PubMed ID: 26179108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical impact of mapping strategies for treatment of ventricular tachycardias in patients with structural heart disease.
    Makimoto H; Nakajima I; Miyamoto K; Yamada Y; Okamura H; Noda T; Aiba T; Kamakura S; Kusano K; Shimizu W; Satomi K
    Pacing Clin Electrophysiol; 2015 May; 38(5):630-40. PubMed ID: 25639823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.